MoneyWorks4Me

Par Drugs & Chem. - Quaterly Results

15 Feb 2025 Evaluate
Net sales declined -10.91%  to  Rs. 213.81 million from Rs. 239.99 millions.The company reported a drastic decline of -83.08% in the quarter ended December 2024 to Rs. 5.79  millions from Rs. 34.21 millions  .A decline of 17.01 millions was observed in the OP in the quarter ended December 2024 from 54.57 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 213.81 239.99 -10.91 786.44 728.21 8.00 956.40 957.49 -0.11
Other Income 2.72 2.29 18.78 13.62 2.90 369.66 2.42 2.38 1.68
PBIDT 17.01 54.57 -68.83 184.34 170.13 8.35 230.60 184.45 25.02
Interest 0.14 0.20 -30.00 0.63 0.63 0.00 1.07 1.33 -19.55
PBDT 16.87 54.37 -68.97 183.71 169.50 8.38 229.53 183.12 25.34
Depreciation 9.14 8.65 5.66 27.26 25.44 7.15 34.36 32.33 6.28
PBT 7.73 45.72 -83.09 156.45 144.06 8.60 195.17 150.79 29.43
TAX 1.94 11.51 -83.15 39.37 36.26 8.58 50.16 37.45 33.94
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.40 -0.50 -180.00
PAT 5.79 34.21 -83.08 117.08 107.80 8.61 145.01 113.34 27.94
Equity 123.05 123.05 0.00 123.05 123.05 0.00 123.05 123.05 0.00
PBIDTM(%) 7.96 22.74 -65.01 23.44 23.36 0.33 24.11 19.26 25.16
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..